Daily Newsroom
Follow market-moving stories, policy signals, and company developments curated by the editorial desk.
Lead story
Wheat futures gained on Wednesday as traders anticipated the U.S. Department of Agriculture's monthly supply and demand report. Potential weather-related harvest delays in Ukraine also appeared to influence market sentiment.
Russia's central bank reported a decrease in the nation's gold reserves in June, while total official reserve assets also declined. Foreign currency reserves, however, remained relatively stable.
Recent disclosures revealed significant stock sales by insiders at Arista Networks and Palantir Technologies, totaling tens of millions of dollars. Conversely, a ten percent owner at Palmer Square Capital BDC Inc. made a substantial purchase of over $647,000 in company stock.
Financial services firm Bernstein has reiterated its "outperform" rating for Ryanair, raising its price target and naming the airline its top European transport pick for the third quarter. The firm argues that the market is undervaluing the carrier's long-term earnings potential.
U.S. President Donald Trump announced on Wednesday that a ceasefire deal with Iran was "over" and warned of additional U.S. military strikes against the country. The comments, made at a NATO summit in Turkey, have escalated tensions and caused a surge in global oil prices.
The South African rand weakened on Wednesday as escalating military tensions between the United States and Iran reduced investor risk appetite, pushing the currency to its lowest level in a week.
Shares of defense technology firm AeroVironment rose significantly after the company released an optimistic long-term financial forecast ahead of its investor day. The outlook includes plans to nearly double revenue by 2030 through organic growth.
President Donald Trump said Monday that the United States would either reach a diplomatic agreement with Iran or resort to military action, a statement made following recently stalled talks. An Iranian official dismissed the threat as 'delusional' as tensions remain high.
Investment firm TD Cowen has named Agios Pharmaceuticals a top biotechnology pick following the U.S. Food and Drug Administration's decision to grant priority review to the company's supplemental New Drug Application for mitapivat in treating sickle cell disease.
